Bright Minds Biosciences Inc. (DRUG)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
DRUG Insider Trading Activity
DRUG Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $7,234,370 | 3 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Cormorant Asset Management, LP | 10 percent owner | 3 | $7.23M | 0 | $0 | $7.23M |
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The …
Insider Activity of Bright Minds Biosciences Inc.
Over the last 12 months, insiders at Bright Minds Biosciences Inc. have bought $7.23M and sold $0 worth of Bright Minds Biosciences Inc. stock.
On average, over the past 5 years, insiders at Bright Minds Biosciences Inc. have bought $7.23M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Cormorant Asset Management, LP (10 percent owner) — $7.23M.
The last purchase of 184,331 shares for transaction amount of $4M was made by Cormorant Asset Management, LP (10 percent owner) on 2024‑11‑04.
List of Insider Buy and Sell Transactions, Bright Minds Biosciences Inc.
| 2024-11-04 | Cormorant Asset Management, LP | 10 percent owner | 184,331 1.3083% | $21.70 | $4M | -24.75% | ||
| 2024-10-16 | Cormorant Asset Management, LP | 10 percent owner | 50,000 0.3836% | $23.46 | $1.17M | +34.13% | ||
| 2024-10-15 | Cormorant Asset Management, LP | 10 percent owner | 372,591 0.6743% | $5.53 | $2.06M | +0.31% |
DRUG Institutional Investors: Active Positions
| Increased Positions | 27 | +385.71% | 5M | +2,552.7% |
| Decreased Positions | 3 | -42.86% | 184,312 | -96.22% |
| New Positions | 25 | New | 5M | New |
| Sold Out Positions | <1 | Sold Out | 100 | Sold Out |
| Total Postitions | 31 | +342.86% | 5M | +2,456.48% |
DRUG Ownership Change vs Market
Institutional Investor Ownership
| Cormorant Asset Management, Lp | $39,449.00 | 15.13% | 1.06M | +1M | New | 2024-12-31 |
| Janus Henderson Group Plc | $18,947.00 | 7.27% | 508,776 | +508,776 | New | 2024-12-31 |
| Commodore Capital Lp | $18,620.00 | 7.14% | 500,000 | +500,000 | New | 2024-12-31 |
| Ra Capital Management, L.P. | $17,161.00 | 6.58% | 460,829 | +460,829 | New | 2024-12-31 |
| Sio Capital Management, Llc | $16,825.00 | 6.45% | 451,793 | +451,793 | New | 2024-12-31 |
| Perceptive Advisors Llc | $15,032.00 | 5.77% | 403,649 | +403,649 | New | 2024-12-31 |
| Vivo Capital, Llc | $9,369.00 | 3.59% | 251,572 | +251,572 | New | 2024-12-31 |
| Logos Global Management Lp | $9,124.00 | 3.5% | 245,000 | +245,000 | New | 2024-12-31 |
| Morgan Stanley | $6,243.00 | 2.4% | 167,640 | +167,640 | New | 2024-12-31 |
| Ikarian Capital, Llc | $5,668.00 | 2.17% | 152,211 | +152,211 | New | 2024-12-31 |